We are live on ! Find out more
MVM

Medicxi Ventures Management Portfolio holdings

AUM $982M
1-Year Est. Return 210.17%
This Fund
S&P 500
This Quarter Est. Return
-14.83%
1 Year Est. Return
+210.17%
3 Year Est. Return
+787.54%
5 Year Est. Return
+404.19%
10 Year Est. Return
–
AUM
$335M
AUM Growth
-$114M
Cap. Flow
-$52.6M
Cap. Flow %
-15.7%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MRUS
Merus
MRUS
+$52.6M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$180M 53.77%
19,963,157
– –
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$708M
$76.9M 22.93%
7,464,572
– –
NAMS icon
3
NewAmsterdam Pharma
NAMS
$3.25B
$55.1M 16.44%
2,869,565
– –
AURA icon
4
Aura Biosciences
AURA
$725M
$23M 6.85%
3,039,892
– –
MRUS
5
DELISTED
Merus
MRUS
– –
-1,169,028
Closed -$52.6M

Similar funds

BIP
Blueprint Investment Partners Greensboro, North Carolina $980M AUM 27.19% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $977M AUM 19.09% 1-Year Est. Return
FCM
Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return
FFS
Forge Financial Services Edmond, Oklahoma $987M AUM 14.12% 1-Year Est. Return
PCM
Polymer Capital Management New York $988M AUM 56.33% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Medicxi Ventures Management's Q2 2024 Portfolio in Review

As of Q2 2024, Medicxi Ventures Management held 5 positions worth $335M, down 25% from $449M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Medicxi Ventures Management withdrew a net $52.6M in Q2 2024, closing 1 position. Its most notable exit was Merus, an estimated $52.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Medicxi Ventures Management fully exited Merus in Q2 2024, selling an estimated $52.6M.
  • Medicxi Ventures Management's ten largest holdings make up 100% of its $335M portfolio in Q2 2024.
  • Medicxi Ventures Management opened 0 new positions and closed 1 in Q2 2024.
  • Medicxi Ventures Management's portfolio value fell 25% quarter-over-quarter to $335M.

Based on Medicxi Ventures Management's 13F filing for Q2 2024, filed 16 Jul 2024.